Public Comments to Agencies
CAGW Files Comments with FCC on RDOF Emergency Petition
CAGW responds to an emergency petition filed by RDOF award winners asking for relief from the FCC's buildout requirements.
CAGW Files Comments to the FCC On Proposed Net Neutrality Rulemaking
The re-classification of the internet as a Title II service will impose heavy-handed regulations and reduce broadband investments.
CAGW Response to House Budget Committee and House Committee on Oversight and Accountability on Improper Payments
Congress should continue to conduct oversight to determine what further steps can be taken to reduce improper payments.
CAGW Files Comments on Federal Trade Commission and Department of Justice Draft Merger Guidance
The draft merger guidance will reduce competition and impose burdensome requirements on businesses across all industries.
CAGW Requests that the U.S. International Trade Commission Should not Expand the TRIPS Waiver
Expanding the COVID-19 TRIPS Wavier will further harm future biopharmaceutical research and development.
CAGW Submits Comments to CMS Against the Proposed Medicare Drug Price Negotiation Program Guidance
The proposed CMS guidance on enacting the IRA will harm patients by hindering drug research and development.
CAGW Response to Senator Thune on Broadband Funding
Broadband services should be properly implemented to prevent waste, fraud, abuse, and mismanagement.
CAGW Files Comments to FTC on Commercial Surveillance and Data Security
CAGW files comments with the Federal Trade Commission on an advanced notice of proposed rulemaking on consumer data privacy.
CAGW Submits Comments to FDA Opposing Menthol Flavor Ban
The proposed rule to ban menthol flavoring will fail to reduce youth cigarette use and harm state and federal budgets.
CAGW Signs Letter on Pole Attachments
VIA ECFS Ms. Marlene H. Dortch Secretary Federal Communications Commission 45 L Street, NE Washington, D.C. 20554
CAGW Comments to FTC on Pharmacy Benefit Managers
Citizens Against Government Waste Files Comments to the FTC regarding Pharmacy Benefit Manager programs.
CAGW Joins Coalition Opposing Proposed SEC Rule on Private Fund Advisors
As consumers face eroding purchasing power because of heightened inflation, affordable investment options are crucial.
